Stockscreener 앱 받기
4.71
4.46%
-0.22
시간 외 거래:
4.80
0.09
+1.91%
전일 마감가:
$4.93
열려 있는:
$4.94
하루 거래량:
198.82K
Relative Volume:
0.46
시가총액:
$83.19M
수익:
-
순이익/손실:
$-30.54M
주가수익비율:
-3.0387
EPS:
-1.55
순현금흐름:
$-18.30M
1주 성능:
+6.08%
1개월 성능:
+16.58%
6개월 성능:
+684.61%
1년 성능:
+935.39%
1일 변동 폭
$4.685
$5.1799
1주일 범위
$4.325
$5.34
52주 변동 폭
$0.3916
$8.2457
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
명칭
Unicycive Therapeutics Inc
전화
650-384-0642
주소
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
UNCY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UNCY
Unicycive Therapeutics Inc
|
4.71 | 87.07M | 0 | -30.54M | -18.30M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | Guggenheim | Buy |
| 2024-04-04 | 개시 | Piper Sandler | Overweight |
Unicycive Therapeutics Inc 주식(UNCY)의 최신 뉴스
Will a bounce in Unicycive Therapeutics Inc. offer an exit2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
What analysts say about Unicycive Therapeutics Inc stockAI-Driven Market Analysis & Invest With Confidence - earlytimes.in
UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders w - PharmiWeb.com
UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - FinancialContent
Did You Lose Money on Unicycive Therapeutics, Inc. (UNCY)? Levi & Korsinsky Urges Investors to Act Before October 14, 2025 - Newsfile
When Will Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Turn A Profit? - Yahoo Finance
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
The Gross Law Firm Reminds Unicycive Therapeutics, Inc. - GlobeNewswire
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit - GuruFocus
UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Unicycive Therapeutics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsUNCY - MarketScreener
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
The Gross Law Firm Reminds Unicycive Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 – UNCY - GlobeNewswire Inc.
Portnoy Law Firm Announces Class Action on Behalf of Unicycive Therapeutics, Inc. Investors - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain OfficersUNCY - PR Newswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - The AI Journal
UNICYCIVE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire
The Gross Law Firm Notifies Shareholders of Unicycive Therapeutics, Inc.(UNCY) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
Class Action Alert: Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of October 14, 2025 Deadline - ACCESS Newswire
ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to ... - Caledonian Record
Join Class Action to Recover Losses from Unicycive Therapeutics, Inc. (UNCY)Contact Levi & Korsinsky Before October 14, 2025 - ACCESS Newswire
UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - GlobeNewswire
Recover Investment Losses: Class Action Initiated Against Unicycive Therapeutics, Inc. (UNCY) - ACCESS Newswire
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
UNICYCIVE REMINDER: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire
UNCY Stockholders Have Opportunity to Lead Unicycive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Morningstar
ROSEN, REGARDED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure ... - Caledonian Record
Unicycive Therapeutics' (UNCY) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Investors in Unicycive Therapeutics, Inc. Should Contact - GlobeNewswire
Shareholders SueWallSt in New Class Action Against Unicycive Therapeutics, Inc.Act Now - Nasdaq
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for InvestorsContact The Gross Law Firm - Barchart.com
UNCY Investors have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire
Investors in Unicycive Therapeutics, Inc. (UNCY): Protect Your RightsContact Levi & Korsinsky Before October 14, 2025 - Newsfile
UNCY DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - GlobeNewswire
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, - GlobeNewswire
MarketsMedicine Hat News - FinancialContent
Holzer & Holzer, LLC Reminds Investors of Upcoming October - GlobeNewswire
Investor Alert: Deadline Approaching to Join Unicycive Therapeutics, Inc. (UNCY) Class ActionContact Levi & Korsinsky - Newsfile
Important Notice to Long-Term Shareholders of Humana Inc. - GlobeNewswire
Shareholders that lost money on Unicycive Therapeutics, Inc.(UNCY) Urged to Join Class ActionContact The Gross Law Firm to Learn More - Sahm
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Contact Levi & Korsinsky Before October 14, 2025 to Join Class Action - ACCESS Newswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure ... - Caledonian Record
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
What machine learning models say about Unicycive Therapeutics Inc.July 2025 Market Mood & Precise Buy Zone Tips - newser.com
UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive - The National Law Review
Securities Fraud Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY)Levi & Korsinsky Reminds Investors of October 14, 2025 - ACCESS Newswire
Unicycive Therapeutics Inc (UNCY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.50%
자본화:
|
볼륨(24시간):